Reflection on “Mitigating the U.S. Drug Shortages through Pareto‐Improving Contracts”

Abstract

The study “Mitigating the U.S. Drug Shortages Through Pareto‐Improving Contracts” was selected as a runner‐up for the Ralph Gomory Best Industry Studies Paper Award by the Industry Studies Association in 2017. The award aims at “explicit recognition of the researchers’ engagement with industry practitioners and demonstrate the benefits of such interactions for scholarly research.” The awarded study addresses the drug shortages problem, a major challenge facing the U.S. pharmaceutical industry and government in recent years. This reflection article provides the “back story” of the study—the motivation, the challenges, the important steps, and the interactions with government agencies and industry practitioners.

Keywords

drug shortage Pareto improvement pharmaceutical supply chain healthcare industry

Get full access to this article

View all access options for this article.

References

ASPE . 2011. Economic analysis of the causes of drug shortages. Technical report, Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services.

Emanuel

E. J.

2011. Shortchanging cancer patients. The New York Times, August 6.

FDA . 2011. A review of FDA's approach to medical product shortages. Technical report, U.S. Food and Drug Administration, U.S. Department of Health and Human Services.

GAO . 2011. Drug shortages: FDA's ability to respond should be strengthened. Technical report, U.S. Government Accountability Office.

Jia

Zhao

. 2017. Mitigating the U.S. drug shortages through pareto‐improving contracts. Prod. Oper. Manag. 26(8): 1463–1480.

Piana

2012. Drug shortages hit oncology hard: Experts weigh in on challenges and solutions. The ASCO Post, February 15.